CWA Asset Management Group LLC increased its position in shares of Monsanto Company (NYSE:MON) by 7.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 18,186 shares of the basic materials company’s stock after buying an additional 1,195 shares during the period. CWA Asset Management Group LLC’s holdings in Monsanto were worth $2,152,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Puplava Financial Services Inc. increased its stake in shares of Monsanto by 0.4% during the second quarter. Puplava Financial Services Inc. now owns 2,119 shares of the basic materials company’s stock worth $251,000 after buying an additional 9 shares during the period. Savant Capital LLC increased its stake in shares of Monsanto by 0.4% during the first quarter. Savant Capital LLC now owns 3,082 shares of the basic materials company’s stock worth $349,000 after buying an additional 11 shares during the period. Guardian Life Insurance Co. of America increased its stake in shares of Monsanto by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the basic materials company’s stock worth $191,000 after buying an additional 11 shares during the period. Enterprise Financial Services Corp increased its stake in shares of Monsanto by 1.2% during the second quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock worth $164,000 after buying an additional 16 shares during the period. Finally, Forward Management LLC increased its stake in shares of Monsanto by 0.5% during the second quarter. Forward Management LLC now owns 3,201 shares of the basic materials company’s stock worth $379,000 after buying an additional 16 shares during the period. Hedge funds and other institutional investors own 74.78% of the company’s stock.

In other news, EVP Steven Mizell sold 11,300 shares of the company’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total value of $1,339,841.00. Following the completion of the sale, the executive vice president now owns 55,011 shares in the company, valued at $6,522,654.27. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Robert T. Fraley sold 52,410 shares of the company’s stock in a transaction on Monday, July 10th. The shares were sold at an average price of $117.95, for a total value of $6,181,759.50. The disclosure for this sale can be found here. Insiders own 0.79% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “CWA Asset Management Group LLC Purchases 1,195 Shares of Monsanto Company (MON)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/09/19/cwa-asset-management-group-llc-purchases-1195-shares-of-monsanto-company-mon.html.

Shares of Monsanto Company (NYSE MON) opened at 119.12 on Tuesday. The firm has a 50-day moving average price of $117.30 and a 200-day moving average price of $116.50. The firm has a market cap of $52.33 billion, a P/E ratio of 25.73 and a beta of 1.07. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $119.59.

Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The company had revenue of $4.23 billion during the quarter, compared to analyst estimates of $4.18 billion. During the same quarter in the previous year, the firm posted $2.17 EPS. The firm’s quarterly revenue was up 1.0% on a year-over-year basis. On average, equities research analysts expect that Monsanto Company will post $4.89 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be given a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.81%. Monsanto’s dividend payout ratio (DPR) is presently 46.75%.

MON has been the topic of a number of recent research reports. Zacks Investment Research upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $131.00 target price on the stock in a research note on Monday, September 4th. BMO Capital Markets reiterated a “buy” rating and issued a $128.00 price target on shares of Monsanto in a research note on Friday, September 1st. BidaskClub lowered shares of Monsanto from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Vetr upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target on the stock in a research note on Wednesday, July 12th. Finally, Susquehanna Bancshares Inc reiterated a “neutral” rating and issued a $128.00 price target (up from $125.00) on shares of Monsanto in a research note on Tuesday, June 27th. Ten equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $124.09.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.